España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
InMed Pharmaceuticals
INM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.40
0.26
6.25%
At close: -
$5.14
0.74
16.85%
After Hours: Dec 16, 7:56 PM EDT
Get Report
Comment
InMed Pharmaceuticals (INM) Forecast
News
Earnings
InMed Pharmaceuticals (INM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for InMed Pharmaceuticals (NASDAQ:INM) Stock
InMed Pharmaceuticals Stock (NASDAQ: INM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
InMed Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
InMed Pharmaceuticals Yesterday Reported Q4 E...
Benzinga Newsdesk
Thursday, November 14, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Monday, October 28, 2024
InMed to Present Alzheimer's Treatment Insigh...
Benzinga Newsdesk
Tuesday, September 10, 2024
InMed Pharmaceuticals shares are trading high...
Benzinga Newsdesk
InMed Pharmaceuticals Granted U.S. Patent US ...
Benzinga Newsdesk
Wednesday, September 04, 2024
Shares Of InMed Pharmaceuticals Seeing Increa...
Benzinga Newsdesk
Thursday, August 22, 2024
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, August 21, 2024
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, August 20, 2024
Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings
Avi Kapoor
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
Avi Kapoor
InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
Vandana Singh
US Stocks Mixed; Lowe's Cuts FY24 Forecast
Avi Kapoor
InMed Pharmaceuticals shares are trading high...
Benzinga Newsdesk
CORRECTTION: InMed Ticker Is 'INM'
Benzinga Newsdesk
InMed Pharmaceuticals Announces INM-901 As A...
Benzinga Newsdesk
Tuesday, July 23, 2024
Inmed Pharmaceuticals Granted U.S. Patent #12...
Benzinga Newsdesk
Thursday, June 06, 2024
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, May 01, 2024
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, April 24, 2024
InMed Pharmaceuticals Has Received A Notice O...
Benzinga Newsdesk
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, April 16, 2024
InMed Pharmaceuticals INM-089 Presented Neuro...
Benzinga Newsdesk
InMed Pharmaceuticals Provides Update On INM...
Benzinga Newsdesk
Thursday, March 07, 2024
InMed Pharmaceuticals Has Received A Notice O...
Benzinga Newsdesk
Friday, February 23, 2024
InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor
Thursday, February 22, 2024
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Thursday, January 25, 2024
InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need
Meg Flippin
-
Sponsored
Thursday, December 21, 2023
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, December 18, 2023
Investment Chief At $48B Global X Forecasts AI Stock Dominance In 2024: Unveils Top Investment Opportunities
Benzinga Neuro
Monday, December 11, 2023
InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog
Meg Flippin
-
Sponsored
Wednesday, October 25, 2023
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, October 24, 2023
InMed Pharmaceuticals Announces $5.2M Private Placement And Preferred Investment Option Exercise Priced At-The-Market under Nasdaq Rules
Happy Mohamed
Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations
Lisa Levin
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings
Lisa Levin
Why InMed Pharmaceuticals Stock Is Soaring Tuesday
Adam Eckert
InMed Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Dow Surges 250 Points; US Manufacturing PMI Tops Expectations
Lisa Levin
InMed Pharmaceuticals Inc Shares Resume Trade
Benzinga Newsdesk
InMed Pharmaceuticals Shares Halted On Circui...
Benzinga Newsdesk
InMed Pharmaceuticals Shares Resume Trading
Benzinga Newsdesk
InMed Pharmaceuticals Shares Halted On Circui...
Happy Mohamed
InMed Pharmaceuticals Shares Resume Trade
Benzinga Newsdesk
InMed Pharmaceuticals Shares Halted On Circui...
Benzinga Newsdesk
Market-Moving News for October 24th
Benzinga Newsdesk
InMed Pharmaceuticals Says INM-901 Demonstrat...
Benzinga Newsdesk
Monday, October 16, 2023
InMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital Conference
Faith Ashmore
Friday, October 13, 2023
Cannabis Industry Report Highlights Positive Sentiment and Growth Potential at Benzinga Conference
Patricio Liddle
Show More